Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

Qiagen NV (QGEN) EUR0.01

Sell:$49.75 Buy:$49.81 Change: $0.67 (1.33%)
Market closed |  Prices as at close on 23 October 2020 | Switch to live prices |
Tender Offer

Qiagen NV EUR0.01

Type:
Tender Offer
Shareholder action required:
Yes
Status:
Update Pending
Details (last updated 24 Jul 2020)

What is happening?

 

Quebec BV (a wholly-owned subsidiary of Thermo Fisher Inc) recently announced a Takeover Offer for all of the Shares in Qiagen NV. The Takeover Offer has now been extended, and the Offer Price has been increased from EUR39.00 to EUR43.00 for each Qiagen NV Share held.

 

What are my options?

 

Option 1 – Do nothing. You are not required to take any action at this time. Depending on the level of acceptance the bidder may seek to delist and/or compulsory acquire any remaining Shares at a later date.

 

Option 2 – Accept the Offer. You can give an instruction to accept the Takeover Offer of EUR43.00 for each Qiagen NV Share held. The deadline to submit an instruction is noon on Tuesday 4 August 2020. Following receipt of your instruction your Shares would be submitted in acceptance of the Offer.

 

IMPORTANT: Please note that we do not have a firm date for when the proceeds from the Takeover Offer will be paid. There may be a lengthy period of time between the deadline for tendering Qiagen NV Shares into the Offer and the Settlement, which is currently expected to occur in the first half of 2021.

 

Will I receive any proceeds in Euros?

 

No, the proceeds will be converted to US Dollars by the bidder based on the simple average of the two WM/Reuters 4:00 p.m. (London time) fixings of the USD/EUR exchange rate on the second (2nd) and third (3rd) day prior to the Settlement Date. The US Dollars will then be converted by to Sterling by Hargreaves Lansdown on the date of their receipt, subject to our standard currency conversion fees.

 

Full details of this event will be sent to Qualifying Hargreaves Lansdown clients by either post or secure message. Please note that any instruction you give must be based on the full details provided in the letter and not on the summary information outlined above.

×
Sell:$49.75
Buy:$49.81
Change: $0.67 (1.33%)
Market closed |  Prices as at close on 23 October 2020 | Switch to live prices |
Tender Offer

Qiagen NV EUR0.01

Type:
Tender Offer
Shareholder action required:
Yes
Status:
Update Pending
Details (last updated 24 Jul 2020)

What is happening?

 

Quebec BV (a wholly-owned subsidiary of Thermo Fisher Inc) recently announced a Takeover Offer for all of the Shares in Qiagen NV. The Takeover Offer has now been extended, and the Offer Price has been increased from EUR39.00 to EUR43.00 for each Qiagen NV Share held.

 

What are my options?

 

Option 1 – Do nothing. You are not required to take any action at this time. Depending on the level of acceptance the bidder may seek to delist and/or compulsory acquire any remaining Shares at a later date.

 

Option 2 – Accept the Offer. You can give an instruction to accept the Takeover Offer of EUR43.00 for each Qiagen NV Share held. The deadline to submit an instruction is noon on Tuesday 4 August 2020. Following receipt of your instruction your Shares would be submitted in acceptance of the Offer.

 

IMPORTANT: Please note that we do not have a firm date for when the proceeds from the Takeover Offer will be paid. There may be a lengthy period of time between the deadline for tendering Qiagen NV Shares into the Offer and the Settlement, which is currently expected to occur in the first half of 2021.

 

Will I receive any proceeds in Euros?

 

No, the proceeds will be converted to US Dollars by the bidder based on the simple average of the two WM/Reuters 4:00 p.m. (London time) fixings of the USD/EUR exchange rate on the second (2nd) and third (3rd) day prior to the Settlement Date. The US Dollars will then be converted by to Sterling by Hargreaves Lansdown on the date of their receipt, subject to our standard currency conversion fees.

 

Full details of this event will be sent to Qualifying Hargreaves Lansdown clients by either post or secure message. Please note that any instruction you give must be based on the full details provided in the letter and not on the summary information outlined above.

×
Sell:$49.75
Buy:$49.81
Change: $0.67 (1.33%)
Market closed |  Prices as at close on 23 October 2020 | Switch to live prices |
Tender Offer

Qiagen NV EUR0.01

Type:
Tender Offer
Shareholder action required:
Yes
Status:
Update Pending
Details (last updated 24 Jul 2020)

What is happening?

 

Quebec BV (a wholly-owned subsidiary of Thermo Fisher Inc) recently announced a Takeover Offer for all of the Shares in Qiagen NV. The Takeover Offer has now been extended, and the Offer Price has been increased from EUR39.00 to EUR43.00 for each Qiagen NV Share held.

 

What are my options?

 

Option 1 – Do nothing. You are not required to take any action at this time. Depending on the level of acceptance the bidder may seek to delist and/or compulsory acquire any remaining Shares at a later date.

 

Option 2 – Accept the Offer. You can give an instruction to accept the Takeover Offer of EUR43.00 for each Qiagen NV Share held. The deadline to submit an instruction is noon on Tuesday 4 August 2020. Following receipt of your instruction your Shares would be submitted in acceptance of the Offer.

 

IMPORTANT: Please note that we do not have a firm date for when the proceeds from the Takeover Offer will be paid. There may be a lengthy period of time between the deadline for tendering Qiagen NV Shares into the Offer and the Settlement, which is currently expected to occur in the first half of 2021.

 

Will I receive any proceeds in Euros?

 

No, the proceeds will be converted to US Dollars by the bidder based on the simple average of the two WM/Reuters 4:00 p.m. (London time) fixings of the USD/EUR exchange rate on the second (2nd) and third (3rd) day prior to the Settlement Date. The US Dollars will then be converted by to Sterling by Hargreaves Lansdown on the date of their receipt, subject to our standard currency conversion fees.

 

Full details of this event will be sent to Qualifying Hargreaves Lansdown clients by either post or secure message. Please note that any instruction you give must be based on the full details provided in the letter and not on the summary information outlined above.

×
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.
Open:
$50.00
Trade high:
$50.00
Year high:
$55.26
Market capitalisation
Market cap.
:
$11.68 bn
Previous close:
$50.48
Trade low:
$49.46
Year low:
$27.99
Shares in issue
Shares
:
228.49 m
Previous:
$0.10 (0.20%)
Previous:
$0.10
Volume:
n/a
Dividend yield:
n/a
Currency:
USD
Data delayed by at least 15 minutes.

Fundamental data

Year ending: 31/12/2011 31/12/2010
Revenue ($m) 1,169.75 1,087.43
Profit before tax ($m) 96.21 173.12
Adjusted EPS (¢): 42.58 64.38
P/E ratio 33.70 31.50
PEG n/a n/a
EPS growth (%) (34.00) (8.00)
Total dividend ($): 0.00 0.00
Dividend yield (%): 0.00 0.00
Dividend cover: n/a n/a

Values are quoted in the stock's local currency: US dollar

All fundamental data

Ready to invest?

To buy shares in , you'll need to have an account. Try our handy filter to explore the different options.

Compare accounts

Ready to take your first step?

To invest in , you'll need to open an account.
Try our handy filter to find which one suits you best.

Compare accounts

Important Documents

There are no documents available for this stock.

Dividend information for this stock is not available.

Dividend information for this stock is not available.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Prices provided by Reuters. Charts provided by Factset. 'Broker forecast' and 'Recent trades' provided by MoneyAM. News and fundamental data provided by Digital Look. Exchange disclaimer

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.